Stock Market Watch

WuXi PharmaTech – Issues in-line guidance for FY11

by ·




WuXi PharmaTech (Cayman) Inc. (ADR) (NYSE:WX). Last Market Price: 11.95, Change: +0.58, % Change: (5.10%). Shares trade in the range of 11.66 – 12.21 dollars. It has a market capitalization of 848.47M dollars, making it a Small Cap Stock and has 71.00M outstanding shares. The company has a beta of 1.81, indicating, the stock to be more volatile than the market. As per the most recent quarterly report, the net income per share (EPS) is 1.32; P/E of 9.09 indicating that the stock may be undervalued. It operates in Healthcare sector and belongs to Biotechnology and Drugs industry. Percentage shares held by institutional investors is 79%. The company has a 52 week Price range (low – high) of $ 10.95 – 19.10. Average volumes of shares traded daily are 289,328. Volume traded in the last session was at 164,534, 0.57 times the average volume.

  • Reports Q3 (Sep)
    • EPS of $0.31, better than the market estimates
    • Revenues rose 24.1% year on year to $104 million
  • Company issues in-line guidance for FY11, sees FY11 revs of $402-406 million, from $400-407 million

For Q2 (Jun ’11), It had a Net profit margin of 18.45%, an Operating margin of 21.28%. Other Key stats and ratios are : Return on average assets of 13.60%, Return on average equity of 17.33%. The organization has an employee strength of 4,465

Consensus Recommendation is a Buy.


Estimate for sales for the Year Ending Dec-11 show a mean of 405.23 million dollars, an estimate high of 410.25 million dollars and an estimate low of 403.00 million dollars. A year ago the figures stood at 388.73 million dollars.

Estimate for sales for the Year Ending Dec-12 show a mean of 471.77 million dollars, an estimate high of 490.32 million dollars and an estimate low of 456.25 million dollars. A year ago the figures stood at 462.60 million dollars.

Estimate for EPS for the Year Ending Dec-11 show a mean of 1.05 dollars, an estimate high of 1.20 dollars and an estimate low of 0.95 dollars. A year ago the figures stood at 1.01 dollars.

Estimate for EPS for the Year Ending Dec-12 show a mean of 1.22 dollars, an estimate high of 1.38 dollars and an estimate low of 1.07 dollars. A year ago the figures stood at 1.30 dollars.

Sales for Quarter Ending Sep-11 was estimated at 102.21 million dollars, however the actual sales figure stood at 103.97 million dollars, 1.76 million dollars more than estimates.

Sales for Quarter Ending Jun-11 was estimated at 98.18 million dollars, however the actual sales figure stood at 101.11 million dollars, 2.93 million dollars more than estimates.

edliston
Post Written By: Ed Liston

Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications. He is widely quoted in various financial publications on the Internet. When Ed is not writing about stocks, investing in stocks, talking about stocks, or otherwise doing something stock related, he likes to go sailing and fishing in his yacht.


Tags:

Ed Liston

Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications. He is widely quoted in various financial publications on the Internet. When Ed is not writing about stocks, investing in stocks, talking about stocks, or otherwise doing something stock related, he likes to go sailing and fishing.

You may also like...